Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway–tumour–stroma lung cancer model

Christophe Mas, Samuel Constant, Bernadett Boda et al.|Journal of Biotechnology|2015

Cited by 24